Access Vascular is focused on developing advanced venous access devices designed to significantly reduce complications associated with intravenous therapy, such as infection, thrombosis, and phlebitis. Founded in 2015, the company utilizes patented biomaterials to create products that have shown to result in six times fewer complications compared to traditional methods. Access Vascular is committed to improving patient outcomes and enhancing safety within the healthcare industry. Collaboration, innovation, and a dedication to quality service are central to its operations, as the company aims to address pressing challenges in medical treatment with effective solutions that meet the highest standards of care.